Unknown

Dataset Information

0

Co-consuming green tea with raloxifene decreases raloxifene systemic exposure in healthy adult participants.


ABSTRACT: Green tea is a popular beverage worldwide. The abundant green tea catechin (-)-epigallocatechin gallate (EGCG) is a potent in vitro inhibitor of intestinal UDP-glucuronosyltransferase (UGT) activity (Ki  ~2 μM). Co-consuming green tea with intestinal UGT drug substrates, including raloxifene, could increase systemic drug exposure. The effects of a well-characterized green tea on the pharmacokinetics of raloxifene, raloxifene 4'-glucuronide, and raloxifene 6-glucuronide were evaluated in 16 healthy adults via a three-arm crossover, fixed-sequence study. Raloxifene (60 mg) was administered orally with water (baseline), with green tea for 1 day (acute), and on the fifth day after daily green tea administration for 4 days (chronic). Unexpectedly, green tea decreased the geometric mean green tea/baseline raloxifene AUC0-96h ratio to ~0.60 after both acute and chronic administration, which is below the predefined no-effect range (0.75-1.33). Lack of change in terminal half-life and glucuronide-to-raloxifene ratios indicated the predominant mechanism was not inhibition of intestinal UGT. One potential mechanism includes inhibition of intestinal transport. Using established transfected cell systems, a green tea extract normalized to EGCG inhibited 10 of 16 transporters tested (IC50 , 0.37-12 μM). Another potential mechanism, interruption by green tea of gut microbe-mediated raloxifene reabsorption, prompted a follow-up exploratory clinical study to evaluate the potential for a green tea-gut microbiota-drug interaction. No clear mechanisms were identified. Overall, results highlight that improvements in current models and methods used to predict UGT-mediated drug interactions are needed. Informing patients about the risk of co-consuming green tea with raloxifene may be considered.

SUBMITTER: Clarke JD 

PROVIDER: S-EPMC10582660 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Co-consuming green tea with raloxifene decreases raloxifene systemic exposure in healthy adult participants.

Clarke John D JD   Judson Sabrina M SM   Tian Dan-Dan DD   Kirby Trevor O TO   Tanna Rakshit S RS   Matula-Péntek Adrienn A   Horváth Miklós M   Layton Matthew E ME   White John R JR   Cech Nadja B NB   Thummel Kenneth E KE   McCune Jeannine S JS   Shen Danny D DD   Paine Mary F MF  

Clinical and translational science 20230828 10


Green tea is a popular beverage worldwide. The abundant green tea catechin (-)-epigallocatechin gallate (EGCG) is a potent in vitro inhibitor of intestinal UDP-glucuronosyltransferase (UGT) activity (K<sub>i</sub>  ~2 μM). Co-consuming green tea with intestinal UGT drug substrates, including raloxifene, could increase systemic drug exposure. The effects of a well-characterized green tea on the pharmacokinetics of raloxifene, raloxifene 4'-glucuronide, and raloxifene 6-glucuronide were evaluated  ...[more]

Similar Datasets

| S-EPMC5677327 | biostudies-literature
| S-EPMC3946959 | biostudies-literature
| S-EPMC7576630 | biostudies-literature
| S-EPMC11016062 | biostudies-literature
| S-EPMC9747113 | biostudies-literature
| S-EPMC5245864 | biostudies-literature
| S-EPMC1783848 | biostudies-literature
| S-EPMC7993260 | biostudies-literature
| S-EPMC9734194 | biostudies-literature
| S-EPMC9335207 | biostudies-literature